Who invested in AGY Therapeutics?
AGY Therapeutics's investors include Novartis Venture Fund, Alta Partners, Gimv, GE Capital and JAFCO Japan, and 4 more on record.
Who invested in AGY Therapeutics
One round we have observed, with the 9 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$9.0Mraised across 1 round since 2004, from 1 source
- Latest round
- Series C, $9.0MAug 2004
- Investors
- 9
The rounds
- Aug 2004Series C$9.0M
Novartis Venture Fund
Alta Partners
Gimv
GE Capital- JAFCO Japan
HBM Partners- Bear Stearns Health Innoventures L.P
- Cheng Xin Technology Development Corp
- Lotus
From a historical funding record
Everyone who backed them
JAFCO JapanVC firm1round
Bear Stearns Health Innoventures L.PVC firm1round
Cheng Xin Technology Development CorpVC firm1round
Lotusno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about AGY Therapeutics
How much has AGY Therapeutics raised?
AGY Therapeutics has raised $9.0M across 1 round since 2004.
When did AGY Therapeutics last raise?
AGY Therapeutics's most recent round was a Series C of $9.0M in Aug 2004.
What was AGY Therapeutics's biggest round?
Its most recent round, $9.0M in Aug 2004, is also its largest on record.
Who backed AGY Therapeutics first?
AGY Therapeutics's first round on record, in Aug 2004, was backed by Novartis Venture Fund, Alta Partners and Gimv and 6 others.
What stage is AGY Therapeutics at?
AGY Therapeutics's latest named round is a Series C, in Aug 2004.
Companies like AGY Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.